Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma

Hepatitis B virus (HBV) infection is a main carcinogenic factor of hepatocellular carcinoma (HCC). TPX2 microtubule nucleation factor is recently recommended as a novel prognostic biomarker in HBV-infected HCC tissues. This study aimed to explore a TPX2-related ceRNA regulatory network in HBV-infected HCC and the potential impact on HCC prognosis. We comprehensively identified 541 differential expressed lncRNAs (DElncRNAs), 37 DEmiRNAs and 439 DEmRNAs from HBV-related TCGA-HCC cohorts in TPX2low and TPX2high groups. Based on their RNA-RNA interaction and expression analysis, four DElncRNAs (TRHDE-AS1, DLX6-AS1, SNHG14, HOXA11-AS), four DEmiRNAs (miR-23b, miR-320a, miR-589, miR-126) and five DEmRNAs (PKIA, PCDHA2, SHCBP1, PRSS16, KIF18A) in HCC tumor vs normal groups were subjected to the hub regulatory networks analysis and further prognostic value analysis. Importantly, the TRHDE-AS1/miR-23b/PKIA ceRNA network was associated with HCC prognosis. Furthermore, cellular location analysis and base-base interaction analysis indicated that the cytoplasmic lncRNA TRHDE-AS1 was regarded as a ceRNA to sponging miR-23b and then regulating PKIA. Interestingly, correlation analysis suggested the expression correlation between TRHDE-AS1 and PKIA in HCC. Finally, we further performed the methylation and immune infiltration analysis to explore the functional process of PKIA in HCC. We proposed a ceRNA regulatory network may help elucidate the mechanism by which TPX2 contributes to the prognosis of HBV-related HCC..

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

Frontiers in Cellular and Infection Microbiology - 12(2022)

Sprache:

Englisch

Beteiligte Personen:

Gaopeng Li [VerfasserIn]
Zhuangqiang Wang [VerfasserIn]
Dong Chen [VerfasserIn]
Jun Yin [VerfasserIn]
Zhiyuan Mo [VerfasserIn]
Bianyin Sun [VerfasserIn]
Tao Yang [VerfasserIn]
Xinning Zhang [VerfasserIn]
Zhensheng Zhai [VerfasserIn]
Yaoxuan Li [VerfasserIn]
Pinggui Chen [VerfasserIn]
Yunyan Dai [VerfasserIn]
Zhiming Wang [VerfasserIn]
Jun Ma [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.frontiersin.org [kostenfrei]
Journal toc [kostenfrei]

Themen:

CeRNA
Hepatitis B virus
Hepatocellular carcinoma
Immune infiltration
Microbiology
Prognosis

doi:

10.3389/fcimb.2022.1025900

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ078821959